AbbVie Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -37.2% | -15.0% | -43.8% | +139.9% | +29.4% | -76.8% | +215.2% | +36.3% | -25.7% | -26.6% | -10.3% | – | |
| – | -7.1% | -0.1% | +2.7% | -2.4% | +1.1% | -3.0% | +0.5% | +0.6% | -3.7% | -2.6% | -2.7% | – | |
| – | -3.8% | +178.4% | -37.4% | -17.0% | +272.4% | -39.2% | -56.3% | +16.8% | -24.9% | +182.8% | -62.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -83.2% | -44.2% | -1,469.2% | – | -152.9% | – | – | – | -115.1% | – | – | – | |
| – | -6.4% | -5.9% | +24.9% | +3.3% | +16.9% | -19.2% | +14.5% | +87.4% | -34.7% | -19.5% | +0.0% | – | |
| – | +116.8% | +1,098.5% | -88.5% | +649.2% | -77.3% | -60.8% | +60.7% | +176.4% | -55.2% | -60.8% | +108.5% | – | |
| – | 0.0% | +5.6% | -0.8% | +0.0% | +0.0% | +6.3% | -0.5% | +0.0% | +0.0% | +6.0% | -0.5% | – | |
| – | -25.0% | +44,033.3% | -99.3% | +88.9% | +2,005.9% | +168.4% | -98.8% | – | -175.0% | +49,533.3% | -99.4% | – | |
| – | – | – | – | – | +833.5% | – | -91.8% | -949.3% | -26.8% | – | -136.4% | – | |
| – | +67.2% | – | -156.4% | -49.6% | +123.3% | -81.7% | +115.4% | +69.4% | -9.2% | – | -649.9% | – | |
| – | -110.4% | – | -194.0% | – | – | – | – | -164.9% | – | – | -167.8% | – | |
| – | -38.2% | -15.4% | -47.2% | +156.1% | +30.0% | -79.3% | +248.9% | +54.1% | -35.1% | -27.1% | +3.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.